Plant Comparison
Oregon Grape vs Mallow
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Oregon Grape and Mallow: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Oregon Grape | Mallow | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 7/10 | 1/10 | Stronger for Oregon Grape |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Mallow |
| Infection (general) | 2/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 7/10 | 2/10 | Stronger for Oregon Grape |
| Skin irritation | 8/10 | 2/10 | Stronger for Oregon Grape |
| Wounds | 1/10 | 5/10 | Stronger for Mallow |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The high mucilage content gives the demulcent, soothing action.
The blue-purple pigments and antioxidant constituents.
Phenolic constituents associated with antioxidant and reported antiproliferative (anticancer) activity in cell studies.
Pharmacological Actions
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory, analgesic and wound-healing (preclinical)
Antibacterial / antimicrobial (methanolic leaf extracts; the naphthoquinone Malvone A)
Demulcent for irritation of the mouth or throat and associated dry cough (soothing mucilage); Mild laxative for occasional constipation (mucilage; traditional)
Mild laxative for occasional constipation (mucilage; traditional)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
Topical for atopic dermatitis (eczema) and skin irritation
Antimicrobial (berberine) - supports skin and mucosal infection
inferred from anti-inflammatory action
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis); Topical treatment of mild-to-moderate psoriasis (reduces plaque severity) - a double-blind, placebo-controlled RCT showed significant improvement in PASI and quality-of-life scores
Topical for atopic dermatitis (eczema) and skin irritation
inferred from anti-inflammatory action
inferred from anticancer action
Mild laxative for occasional constipation (mucilage; traditional)
Demulcent for irritation of the mouth or throat and associated dry cough (soothing mucilage)
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from analgesic action
Soothes irritated and inflamed skin and mucous membranes
Safety, Cautions & Contraindications
Avoid internal use in pregnancy and breastfeeding: like goldenseal, the berberine it contains can cross the placenta and into milk and worsen newborn jaundice (kernicterus risk).
Generally very well tolerated. Irritation of the mouth/throat or a cough that persists beyond about a week, or is accompanied by fever or breathlessness, needs medical assessment.
Use in pregnancy and breastfeeding is not recommended in the absence of adequate data.
External Ids
Botanical Description
Evergreen shrub, 0.5-2 m tall, spreading by underground rhizomes to form thickets. The pinnate leaves resemble holly, with 5-9 glossy, dark green, spiny-toothed leaflets that often turn bronze-red in winter. Small, bright yellow, six-petalled flowers are borne in dense, upright terminal racemes in early spring, followed by clusters of blue-black, grape-like berries with a waxy bloom. The wood and inner bark of the stem and root are bright yellow when cut, owing to their high content of berberine-type alkaloids.
Biennial or short-lived perennial herb, 30-120 cm tall, with erect or sprawling, branched, often reddish stems. Leaves are alternate, long-stalked and palmately lobed with 5-7 shallow rounded lobes and toothed margins. Flowers are pink-purple with darker veining, with five notch-tipped petals borne in small axillary clusters. The fruit is a flattened, disc-shaped schizocarp ('cheese') that splits into a ring of small single-seeded nutlets.[2]
Habitat
Native to the Pacific Northwest of North America, growing in coniferous woodland understorey, forest margins and rocky slopes; widely introduced and naturalised as an ornamental and hedging shrub in temperate regions elsewhere.
Common on roadsides, waste ground, hedgebanks and field margins across Europe, North Africa and temperate Asia, and widely naturalised elsewhere; tolerates a wide range of soils, favouring sunny, disturbed, nitrogen-rich sites.[2]
Harvesting
The root and root bark, the medicinal parts, are dug from established plants - traditionally in autumn - and dried. Because wild populations are slow-growing, cultivated or nursery-sourced material is preferred over wild-harvesting.
Leaves and flowers are gathered during the flowering period (summer) and dried quickly out of direct sun to preserve their mucilage content; fresh material can also be used directly for infusions or poultices.[11]
Traditional Uses
Oregon grape root has a traditional Native American and Eclectic-medicine history as a bitter tonic and alterative (blood-purifying) remedy and for skin conditions. Its main modern use, supported by clinical trials, is topical application of a standardised bark extract for mild-to-moderate psoriasis and atopic dermatitis (eczema), where its berberine-type alkaloids give anti-inflammatory and antiproliferative effects on skin cells.[1, 11, 12]
Mallow leaf and flower have a long ethnobotanical history across Europe as a demulcent for irritated mucous membranes - soothing coughs, sore throat and mouth irritation - and for occasional constipation and skin irritation, reflecting the mucilage-rich leaf and flower. Modern phytochemical and pharmacological work confirms antioxidant, anti-inflammatory, antimicrobial and wound-healing activity of its extracts.[2, 11]
Preparations
Dosage
EMA herbal-monograph guidance suggests roughly 1.5-2 g of dried leaf or flower per cup, taken as an infusion up to 3 times daily. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Gulliver, W.P. and Donsky, H.J (2005) 'A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis', American Journal of Therapeutics, 12(5), pp. 398-406. doi:10.1097/01.mjt.0000174350.82270.da Clinical study
https://doi.org/10.1097/01.mjt.0000174350.82270.da - Cernakova, M. and Kostalova, D (2002) 'Antimicrobial activity of berberine--a constituent of Mahonia aquifolium', Folia Microbiologica, 47(4), pp. 375-378. doi:10.1007/BF02818693 Preclinical
https://doi.org/10.1007/BF02818693 - Damjanovic, A., Kolundzija, B., Matic, I.Z., Krivokuca, A. and others (2020) 'Mahonia aquifolium Extracts Promote Doxorubicin Effects against Lung Adenocarcinoma Cells In Vitro', Molecules, 25(22), pp. 5233. doi:10.3390/molecules25225233 Preclinical
https://doi.org/10.3390/molecules25225233 - Cernakova, M., Kostalova, D., Kettmann, V., Plodova, M. and others (2002) 'Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium', BMC Complementary and Alternative Medicine, 2, pp. 2. doi:10.1186/1472-6882-2-2 Preclinical
https://doi.org/10.1186/1472-6882-2-2 - Slobodnikova, L., Kostalova, D., Labudova, D., Kotulova, D. and Kettmann, V (2004) 'Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids', Phytotherapy Research, 18(8), pp. 674-676. doi:10.1002/ptr.1517 Preclinical
https://doi.org/10.1002/ptr.1517 - Godjevac, D., Damjanovic, A., Stanojkovic, T.P., Andjelkovic, B. and Zdunic, G (2018) 'Identification of cytotoxic metabolites from Mahonia aquifolium using 1H NMR-based metabolomics approach', Journal of Pharmaceutical and Biomedical Analysis, 150, pp. 9-14. doi:10.1016/j.jpba.2017.11.075 Preclinical
https://doi.org/10.1016/j.jpba.2017.11.075 - Muller, K. and Ziereis, K (1994) 'The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase', Planta Medica, 60(5), pp. 421-424. doi:10.1055/s-2006-959523 Preclinical
https://doi.org/10.1055/s-2006-959523 - Rohrer, U., Kunz, E.M.K., Lenkeit, K., Schaffner, W. and Meyer, J (2007) 'Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria', Schweizer Monatsschrift fur Zahnmedizin, 117(11), pp. 1126-1131. Preclinical
https://scholar.google.com/scholar?q=Antimicrobial%20activity%20of%20Mahonia%20aquifolium%20and%20two%20of%20its%20alkaloids%20against%20oral%20bacteria - Vollekova, A., Kostalova, D., Kettmann, V. and Toth, J (2003) 'Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids', Phytotherapy Research, 17(7), pp. 834-837. doi:10.1002/ptr.1256 Preclinical
https://doi.org/10.1002/ptr.1256 - Hajnicka, V., Kostalova, D., Svecova, D., Sochorova, R. and others (2002) 'Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1', Planta Medica, 68(3), pp. 266-268. doi:10.1055/s-2002-23126 Preclinical
https://doi.org/10.1055/s-2002-23126 - Gulliver, W.P. and colleagues (2018) 'Review of the Efficacy and Safety of Topical Mahonia aquifolium for the Treatment of Psoriasis and Atopic Dermatitis', Journal of Clinical and Aesthetic Dermatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ Meta-analysis / review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ - Herbal Reality (n.d.) 'Oregon Grape Root (Berberis aquifolium): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/oregon-grape/ Traditional / reference
https://www.herbalreality.com/herb/oregon-grape/ - Bernstein, S., Donsky, H., Gulliver, W., Hamilton, D., Nobel, S. and Norman, R (2006) 'Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract - a double-blind, placebo-controlled study', American Journal of Therapeutics, 13(2), pp. 121--126. doi:10.1097/00045391-200603000-00007 Randomized trial
https://doi.org/10.1097/00045391-200603000-00007
- Mousavi, S.M., Hashemi, S.A., Behbudi, G., Mazraedoost, S. and others (2021) 'A Review on Health Benefits of Malva sylvestris L. Nutritional Compounds for Metabolites, Antioxidants, and Anti-Inflammatory, Anticancer, and Antimicrobial Applications', Evidence-Based Complementary and Alternative Medicine, 2021, pp. 5548404. doi:10.1155/2021/5548404 Meta-analysis / review
https://doi.org/10.1155/2021/5548404 - Gasparetto, J.C., Martins, C.A., Hayashi, S.S., Otuky, M.F. and others (2012) 'Ethnobotanical and scientific aspects of Malva sylvestris L.: a millennial herbal medicine', Journal of Pharmacy and Pharmacology, 64(2), pp. 172-189. doi:10.1111/j.2042-7158.2011.01383.x Meta-analysis / review
https://doi.org/10.1111/j.2042-7158.2011.01383.x - Wu, Y., Qiu, A., Yang, Z., Wu, J. and others (2019) 'Malva sylvestris extract alleviates the astrogliosis and inflammatory stress in LPS-induced depression mice', Journal of Neuroimmunology, 336, pp. 577029. doi:10.1016/j.jneuroim.2019.577029 Preclinical
https://doi.org/10.1016/j.jneuroim.2019.577029 - Ben Saad, A., Rjeibi, I., Brahmi, D., Smida, A. and others (2016) 'Malva sylvestris extract protects upon lithium carbonate-induced kidney damages in male rat', Biomedicine & Pharmacotherapy, 84, pp. 1099-1107. doi:10.1016/j.biopha.2016.10.026 Preclinical
https://doi.org/10.1016/j.biopha.2016.10.026 - Zuo, H., Li, Y., Cui, Y. and An, Y (2017) 'Cardioprotective effect of Malva sylvestris L. in myocardial ischemic/reperfused rats', Biomedicine & Pharmacotherapy, 95, pp. 679-684. doi:10.1016/j.biopha.2017.08.111 Preclinical
https://doi.org/10.1016/j.biopha.2017.08.111 - Benso, B., Rosalen, P.L., Alencar, S.M. and Murata, R.M (2015) 'Malva sylvestris Inhibits Inflammatory Response in Oral Human Cells. An In Vitro Infection Model', PLoS One, 10(10), pp. e0140331. doi:10.1371/journal.pone.0140331 Preclinical
https://doi.org/10.1371/journal.pone.0140331 - Prudente, A.S., Sponchiado, G., Mendes, D.A.G.B., Soley, B.S. and others (2017) 'Pre-clinical efficacy assessment of Malva sylvestris on chronic skin inflammation', Biomedicine & Pharmacotherapy, 93, pp. 852-860. doi:10.1016/j.biopha.2017.06.083 Preclinical
https://doi.org/10.1016/j.biopha.2017.06.083 - Mohaghegh, Z., Golfakhrabadi, F., Faal Siahkal, S., Dastoorpoor, M. and others (2022) 'The Effect of Malva sylvestris Cream on Episiotomy Pain and Healing: A Randomized Controlled Clinical Trial', International Journal of Community Based Nursing and Midwifery, 10(4), pp. 248-258. doi:10.30476/IJCBNM.2022.95772.2082 Randomized trial
https://doi.org/10.30476/IJCBNM.2022.95772.2082 - Areesanan, A., Nicolay, S., Keller, M., Zimmermann-Klemd, A.M. and others (2023) 'Potential benefits of Malva sylvestris in dry-eye disease pathology in vitro based on antioxidant, wound-healing and anti-inflammatory properties', Biomedicine & Pharmacotherapy, 168, pp. 115782. doi:10.1016/j.biopha.2023.115782 Preclinical
https://doi.org/10.1016/j.biopha.2023.115782 - Martins, C.A., Weffort-Santos, A.M., Gasparetto, J.C., Trindade, A.C. and others (2014) 'Malva sylvestris L. extract suppresses desferrioxamine-induced PGE2 and PGD2 release in differentiated U937 cells', Biomedical Chromatography, 28(7), pp. 986-993. doi:10.1002/bmc.3106 Preclinical
https://doi.org/10.1002/bmc.3106 - European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Malva sylvestris L., folium and flos (Malvae folium / Malvae sylvestris flos)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/malvae-folium Traditional / reference
https://www.ema.europa.eu/en/medicines/herbal/malvae-folium - Paul, Z.A. and Malla, A.T. and Dar, M.A. and Masoodi, M.H (2024) 'Phytochemistry and Pharmacological Activity of Malva sylvestris L.: A Detailed Insight', Combinatorial Chemistry & High Throughput Screening, 27(16), pp. 2309--2322. doi:10.2174/0113862073269336231009110313 Traditional / reference
https://doi.org/10.2174/0113862073269336231009110313 - Batiha, G.E. and Tene, S.T. and Teibo, J.O. and Shaheen, H.M. and Oluwatoba, O.S. and Teibo, T.K.A. and Al-Kuraishy, H.M. and Al-Garbee, A.I. and Alexiou, A. and Papadakis, M (2022) 'The phytochemical profiling, pharmacological activities, and safety of Malva sylvestris: a review', Naunyn-Schmiedeberg's Archives of Pharmacology, 396(3), pp. 421--440. doi:10.1007/s00210-022-02329-w Traditional / reference
https://doi.org/10.1007/s00210-022-02329-w
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.